Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
64.057,96
1,86%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Canada TSXV Intelgenx Technologies Corp (IGX) Intelgenx Technologies Corp (IGX) Notizie

IGX

Intelgenx Technologies (IGX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSXV:IGX
DataOraFonteTitoloSimboloCompagnia
27/03/202016:54PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - IGXTSXV:IGXIntelgenx Technologies Corp
27/03/202016:52PR Newswire (Canada)IIROC Trading Resumption - IGXTSXV:IGXIntelgenx Technologies Corp
27/03/202015:04PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - Enter Symbol(s) HereTSXV:IGXIntelgenx Technologies Corp
27/03/202015:02PR Newswire (Canada)IIROC Trading Halt - IGXTSXV:IGXIntelgenx Technologies Corp
19/12/201922:32PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - IGXTSXV:IGXIntelgenx Technologies Corp
18/10/201816:08PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - IGX ; IGX.DBTSXV:IGXIntelgenx Technologies Corp
18/10/201816:07PR Newswire (Canada)IIROC Trading Resumption - IGX; IGX.DBTSXV:IGXIntelgenx Technologies Corp
17/10/201822:31PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - IGX, IGX.DBTSXV:IGXIntelgenx Technologies Corp
17/10/201822:28PR Newswire (Canada)IIROC Trading Halt - IGX, IGX.DBTSXV:IGXIntelgenx Technologies Corp
05/12/201715:53PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - IGX; IGX.DBTSXV:IGXIntelgenx Technologies Corp
05/12/201715:27PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - IGX IGX.DBTSXV:IGXIntelgenx Technologies Corp
05/12/201715:24PR Newswire (Canada)IIROC Trading Halt - IGX IGX.DBTSXV:IGXIntelgenx Technologies Corp
15/11/201114:16MarketwiredSpeculative Healthcare Companies IntelGenx and Adventrx Begin to Gain GroundTSXV:IGXIntelgenx Technologies Corp
09/08/201112:00MarketwiredIntelGenx Reports Q2, 2011 Results and Highlights Recent DevelopmentsTSXV:IGXIntelgenx Technologies Corp
02/08/201112:00MarketwiredIntelGenx Announces Successful Pre-Approval Inspection of its Lead Product CPI-300TSXV:IGXIntelgenx Technologies Corp
22/06/201116:35MarketwiredIntelGenx Announces Closing of Private PlacementsTSXV:IGXIntelgenx Technologies Corp
14/06/201118:36MarketwiredIntelGenx Announces Licensing of Anti-Psychotic VersaFilm ProductTSXV:IGXIntelgenx Technologies Corp
14/06/201112:00MarketwiredIntelGenx Announces New PDUFA Date for Its Single Dose 450 mg Bupropion Hydrochloride TabletTSXV:IGXIntelgenx Technologies Corp
03/06/201115:45MarketwiredIntelGenx Announces Up to Approximately US$3 Million Equity Offering of Common Stock and WarrantsTSXV:IGXIntelgenx Technologies Corp
24/05/201112:00MarketwiredIntelGenx Welcomes Dr. Rajiv Khosla to Its BoardTSXV:IGXIntelgenx Technologies Corp
16/05/201112:00MarketwiredIntelGenx Submits Reply to FDA Complete Response Letter for its Single Dose 450 mg Bupropion Hydrochloride TabletTSXV:IGXIntelgenx Technologies Corp
11/05/201112:00MarketwiredIntelGenx Reports Q1, 2011 Results and Highlights Recent DevelopmentsTSXV:IGXIntelgenx Technologies Corp
06/04/201112:00MarketwiredIntelGenx Completes Positive Bioequivalence Study with Insomnia Thin FilmTSXV:IGXIntelgenx Technologies Corp
30/03/201112:00MarketwiredIntelGenx Reports 2010 Financial Results and Summarizes Key DevelopmentsTSXV:IGXIntelgenx Technologies Corp
04/03/201120:36MarketwiredIntelGenx Announces Departure of DirectorTSXV:IGXIntelgenx Technologies Corp
07/02/201112:00MarketwiredIntelGenx Achieves Positive Bioequivalence Results for a Leading Branded Anti-Psychotic Using VersaFilm Oral Thin Film TechnologTSXV:IGXIntelgenx Technologies Corp
03/02/201112:00MarketwiredIntelGenx Announces Dismissal of Patent Litigation Relating to Its Once Daily High Dose 450 mg Bupropion Hydrochloride TabletTSXV:IGXIntelgenx Technologies Corp
05/01/201112:00MarketwiredIntelGenx to Present at OneMedForum Conference in San FranciscoTSXV:IGXIntelgenx Technologies Corp
04/01/201112:00MarketwiredIntelGenx Receives Positive Ruling in Patent Litigation HearingTSXV:IGXIntelgenx Technologies Corp
29/11/201012:00MarketwiredIntelGenx Acquires Full Ownership and Exclusive Rights to MS Induced Pain ProductTSXV:IGXIntelgenx Technologies Corp
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSXV:IGX

La tua Cronologia

BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
STMMI
ST Microelectronics
BIT
BPE
Bper Banca
BIT
BAMI
Banco BPM
BIT
ENI
Eni
BIT
RACE
Ferrari NV
BIT
TIT
Telecom Italia
BIT
SPM
Saipem
BIT
SRG
Snam
BIT
TEN
Tenaris
BIT
TRN
Terna Trasmissione Elett...
BIT
IVG
Iveco Group NV
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network